From the
Robert Koch Institute, the German Federal Institute centre for infectious disease control and part of the
Federal Ministry of Health; their
April 2010 Bulletin
Zur Diagnose einer latenten tuberkulösen Infektion stellen Interferon-Gamma-Release-Assays (IGRA) aufgrund ihrer weit überlegenen Spezifität gegenüber dem Tuberkulinhauttest (THT) einen deutlichen Fortschritt dar
For the diagnosis of a latent tuberculosis infection use interferon gamma release Assays (IGRA) due to their far superior specificity as opposed to the the tuberculin skin test (TST) a clear Progress.
This was apparently in response to the
WHO Global plan to stop TB "2006 - 2015" which
contains the following;
OBJECTIVE 2: Development and evaluation of a portfolio of new diagnostic tools and demonstration of impact
Identification of latent TB infection at risk of progression
Conceptualization and development initiation of test for risk of disease progression in a suitable platform based on best candidates
Introduction of at least one product for point of care use by 2012
